Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119197) titled 'Clinical study of secukinumab in the treatment of chronic sinusitis with nasal polyps' on Feb. 24.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Shanghai Tongji Hospital
Condition:
Chronic Rhinosinusitis with Nasal Polyps
Intervention:
A group(Subcutaneous injection of drugs):None
C group(Surgery + Medication):None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-01
Target Sample Size: A group(Subcutaneous injection of drugs):30;C group(Surgery + Medication):30;B group(Surgery):30;
Countries of Recruitment:
China
To know mor...